Cargando…
Clinical and cost-effectiveness of the Lightning Process in addition to specialist medical care for paediatric chronic fatigue syndrome: randomised controlled trial
OBJECTIVE: Investigate the effectiveness and cost-effectiveness of the Lightning Process (LP) in addition to specialist medical care (SMC) compared with SMC alone, for children with chronic fatigue syndrome (CFS)/myalgic encephalitis (ME). DESIGN: Pragmatic randomised controlled open trial. Particip...
Autores principales: | Crawley, Esther M, Gaunt, Daisy M, Garfield, Kirsty, Hollingworth, William, Sterne, Jonathan A C, Beasant, Lucy, Collin, Simon M, Mills, Nicola, Montgomery, Alan A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865512/ https://www.ncbi.nlm.nih.gov/pubmed/28931531 http://dx.doi.org/10.1136/archdischild-2017-313375 |
Ejemplares similares
-
Comparing specialist medical care with specialist medical care plus the Lightning Process® for chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME): study protocol for a randomised controlled trial (SMILE Trial)
por: Crawley, Esther, et al.
Publicado: (2013) -
The feasibility and acceptability of conducting a trial of specialist medical care and the Lightning Process in children with chronic fatigue syndrome: feasibility randomized controlled trial (SMILE study)
por: Crawley, Esther, et al.
Publicado: (2013) -
The treatment preferences of adolescents and their parents, what has the smile RCT shown us? Smile: specialist medical intervention and lightning evaluation
por: Beasant, Lucy, et al.
Publicado: (2015) -
Paediatric chronic fatigue syndrome patients’ and parents’ perceptions of recovery
por: Harland, Matthew Robert, et al.
Publicado: (2019) -
The feasibility and acceptability of an early intervention in primary care to prevent chronic fatigue syndrome (CFS) in adults: randomised controlled trial
por: O’Dowd, Hazel, et al.
Publicado: (2020)